Orexo Ab operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orexo Ab with three other
companies in this sector in UNITED STATES :
sales of $101.23 million
of which 50%
was Commercial Platform),
of which 100%
was Cancer Therapeutics), and
During the year ended December of 2019, sales at
Orexo Ab were $89.17 million.
decrease of 0.6%
versus 2018, when the company's sales were $89.68 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Orexo Ab had sales
of $82.71 million.